ReviewInternational journal of molecular sciences2024

Targeting Myeloid Differentiation Primary Response Protein 88 (MyD88) and Galectin-3 to Develop Broad-Spectrum Host-Mediated Therapeutics against SARS-CoV-2.

Kamal U Saikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.